Corrigendum: Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1

Corrigendum: Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1

Bibliographic Details
Main Authors:	Catarina E. Hioe, Xiaomei Liu, Andrew N. Banin, Daniel W. Heindel, Je´romine Klingler, Priyanka G. Rao, Christina C. Luo, Xunqing Jiang, Shilpi Pandey, Tracy Ordonez, Philip Barnette, Maxim Totrov, Jiang Zhu, Arthur Na´das, Susan Zolla-Pazner, Chitra Upadhyay, Xiaoying Shen, Xiang-Peng Kong, Ann J. Hessell
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Immunology
Subjects:	HIV-1 vaccine HIV-1 Env antibody immune complex (IC) virus neutralization ADCP
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1329069/full

Similar Items

Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1
by: Catarina E. Hioe, et al.
Published: (2023-10-01)

Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk Leukocytes
by: Alisa Fox, et al.
Published: (2022-05-01)

Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis
by: Aurelio Cafaro, et al.
Published: (2024-01-01)

Identification and characterization of previously described epitopes in HIV-1 subtypes B, C, F and BF in Brazil
by: Artur Trancoso Lopo de Queiroz, et al.

Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines
by: Catarina E. Hioe, et al.
Published: (2018-10-01)

HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model
by: Gabriel Siracusano, et al.
Published: (2021-11-01)

Long Terminal Repeats Region as a Potential Target for HIV Molecular Detection
by: Aroem Naroeni, et al.
Published: (2011-04-01)

Enhancement of Neutralization Responses through Sequential Immunization of Stable Env Trimers Based on Consensus Sequences from Select Time Points by Mimicking Natural Infection
by: Mingming Wan, et al.
Published: (2023-08-01)

Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir
by: Poonam Suryawanshi, et al.
Published: (2021-04-01)

HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse
by: Gaia Vasiliver-Shamis, et al.
Published: (2010-05-01)

A Conserved Tryptophan in the Envelope Cytoplasmic Tail Regulates HIV-1 Assembly and Spread
by: Xenia Snetkov, et al.
Published: (2022-01-01)

Functional and structural segregation of overlapping helices in HIV-1
by: Maliheh Safari, et al.
Published: (2022-05-01)

Unlocking HIV-1 Env: implications for antibody attack
by: Jonathan Richard, et al.
Published: (2017-09-01)

Caracterización de marcadores inmunológicos en pacientes infectados con el virus de la inmunodeficiencia humana (VIH)
by: María Teresa Rugeles López, et al.
Published: (2001-04-01)

Immune Complex Vaccine Strategies to Combat HIV-1 and Other Infectious Diseases
by: Alex F. Tang, et al.
Published: (2021-02-01)

Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals
by: Francisco Martin, et al.
Published: (2022-12-01)

IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters
by: Smita Verma, et al.
Published: (2023-12-01)

HIV-1 Envelope Glycoprotein Trafficking and Viral Transmission
by: Melissa Victoria Fernandez, et al.
Published: (2020-06-01)

Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression
by: Agustín Valenzuela-Fernández, et al.
Published: (2022-09-01)

Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation
by: Cyprien Beraud, et al.
Published: (2018-02-01)

Structure-Guided Redesign Improves NFL HIV Env Trimer Integrity and Identifies an Inter-Protomer Disulfide Permitting Post-Expression Cleavage
by: Lifei Yang, et al.
Published: (2018-07-01)

Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
by: Rebecca Heß, et al.
Published: (2019-02-01)

Validation of HIV-1 MA Shell Structural Arrangements and Env Protein Interactions Predict a Role of the MA Shell in Viral Maturation
by: Tarana A. Mangukia, et al.
Published: (2023-03-01)

Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus–Cell Entry
by: Charles Gotuaco Ang, et al.
Published: (2021-06-01)

A Quantitative Live-Cell Superresolution Imaging Framework for Measuring the Mobility of Single Molecules at Sites of Virus Assembly
by: Nicholas S. Groves, et al.
Published: (2020-11-01)

Glutaraldehyde Cross-linking of HIV-1 Env Trimers Skews the Antibody Subclass Response in Mice
by: Martina Soldemo, et al.
Published: (2017-11-01)

The HIV Env Glycoprotein Conformational States on Cells and Viruses
by: Connie Zhao, et al.
Published: (2022-04-01)

Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
by: Yoann Aldon, et al.
Published: (2021-09-01)

Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies
by: Jennie M. Hutchinson, et al.
Published: (2019-05-01)

Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env
by: Christopher A. Gonelli, et al.
Published: (2021-03-01)

HIV-1 Envelope Glycoprotein Cell Surface Localization Is Associated with Antibody-Induced Internalization
by: Sai Priya Anand, et al.
Published: (2021-09-01)

Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
by: Mitch Brinkkemper, et al.
Published: (2019-07-01)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
by: Marianne Boutin, et al.
Published: (2022-06-01)

Calcium Phosphate Nanoparticle-Based Vaccines as a Platform for Improvement of HIV-1 Env Antibody Responses by Intrastructural Help
by: Dominik Damm, et al.
Published: (2019-09-01)

Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression
by: Qi Wang, et al.
Published: (2019-08-01)

Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses
by: Beatriz Perdiguero, et al.
Published: (2019-12-01)

Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
by: Rebekah Sherburn, et al.
Published: (2021-08-01)

HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton
by: Romina Cabrera-Rodríguez, et al.
Published: (2023-08-01)

Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
by: David Peterhoff, et al.
Published: (2021-06-01)

Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis
by: Jay Lubow, et al.
Published: (2020-07-01)